Developing a mass spectrometry–based assay for the ovarian cancer biomarker CA125 (MUC16) using suspension trapping (STrap)

Effect of Screening on Ovarian Cancer Mortality

Saundra S. Buys · JAMA · 2011 · 1.3K citations

Medicine, Gynecology, Preventive Medicine +17

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Ian Jacobs, Usha Menon, Andy Ryan et al. · The Lancet · 2015 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +14

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Richard G. Moore, D. Scott McMeekin, Amy Brown et al. · Gynecologic Oncology · 2008 · 866 citations

Medicine, Gynecology, Oncology +15

Selective reduction of disulfides by tris(2-carboxyethyl)phosphine

John A. Burns, James C. Butler, John T. Moran et al. · The Journal of Organic Chemistry · 1991 · 689 citations

Natural Sciences, Biochemistry, Chemistry +8

Molecular Cloning of the CA125 Ovarian Cancer Antigen

Beatrice W.T. Yin, Kenneth O. Lloyd · Journal of Biological Chemistry · 2001 · 657 citations · Full text

Medicine, Molecular Biology, Oncology +16